Milestone Pharmaceuticals Stock Price History
| MIST Stock | USD 2.20 0.03 1.38% |
Below is the normalized historical share price chart for Milestone Pharmaceuticals extending back to May 09, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Milestone Pharmaceuticals stands at 2.20, as last reported on the 4th of January, with the highest price reaching 2.39 and the lowest price hitting 2.09 during the day.
If you're considering investing in Milestone Stock, it is important to understand the factors that can impact its price. Milestone Pharmaceuticals appears to be relatively risky, given 3 months investment horizon. Milestone Pharmaceuticals has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18% return per unit of risk over the last 3 months. By analyzing Milestone Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please exercise Milestone Pharmaceuticals' Risk Adjusted Performance of 0.1528, downside deviation of 3.41, and Mean Deviation of 2.4 to check out if our risk estimates are consistent with your expectations.
At this time, Milestone Pharmaceuticals' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 40.9 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 34.5 M in 2025. . At this time, Milestone Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 4.04 in 2025, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.44). Milestone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of May 2019 | 200 Day MA 1.5988 | 50 Day MA 1.7938 | Beta 1.729 |
Milestone |
Sharpe Ratio = 0.1788
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MIST | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.72 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.66 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Milestone Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Milestone Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.8859 | Enterprise Value Ebitda (1.43) | Price Sales 91.9492 | Shares Float 52.8 M | Wall Street Target Price 10.25 |
Milestone Pharmaceuticals Stock Price History Chart
There are several ways to analyze Milestone Stock price data. The simplest method is using a basic Milestone candlestick price chart, which shows Milestone Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 31, 2024 | 2.36 |
| Lowest Price | October 24, 2024 | 1.43 |
Milestone Pharmaceuticals January 4, 2025 Stock Price Synopsis
Various analyses of Milestone Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Milestone Stock. It can be used to describe the percentage change in the price of Milestone Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Milestone Stock.| Milestone Pharmaceuticals Price Action Indicator | (0.02) | |
| Milestone Pharmaceuticals Accumulation Distribution | 89,876 | |
| Milestone Pharmaceuticals Price Rate Of Daily Change | 1.01 | |
| Milestone Pharmaceuticals Price Daily Balance Of Power | 0.10 |
Milestone Pharmaceuticals January 4, 2025 Stock Price Analysis
Milestone Stock Price History Data
The price series of Milestone Pharmaceuticals for the period between Sun, Oct 6, 2024 and Sat, Jan 4, 2025 has a statistical range of 0.93 with a coefficient of variation of 13.68. The daily prices for the period are spread out with arithmetic mean of 1.73. The median price for the last 90 days is 1.8. The company underwent 1-1 stock split on 24th of March 2020.| Open | High | Low | Close | Volume | ||
| 01/03/2025 | 2.16 | 2.39 | 2.09 | 2.20 | 716,010 | |
| 01/02/2025 | 2.39 | 2.39 | 2.17 | 2.17 | 987,908 | |
| 12/31/2024 | 2.28 | 2.75 | 2.28 | 2.36 | 2,618,665 | |
| 12/30/2024 | 2.15 | 2.28 | 2.08 | 2.25 | 784,485 | |
| 12/27/2024 | 1.97 | 2.15 | 1.93 | 2.15 | 568,095 | |
| 12/26/2024 | 1.85 | 1.98 | 1.83 | 1.98 | 550,319 | |
| 12/24/2024 | 1.85 | 1.86 | 1.81 | 1.85 | 129,500 | |
| 12/23/2024 | 1.82 | 1.85 | 1.74 | 1.85 | 293,242 | |
| 12/20/2024 | 1.72 | 1.81 | 1.71 | 1.80 | 287,399 | |
| 12/19/2024 | 1.70 | 1.77 | 1.70 | 1.72 | 273,598 | |
| 12/18/2024 | 1.83 | 1.86 | 1.68 | 1.70 | 415,823 | |
| 12/17/2024 | 1.78 | 1.86 | 1.76 | 1.82 | 171,837 | |
| 12/16/2024 | 1.79 | 1.85 | 1.78 | 1.79 | 239,416 | |
| 12/13/2024 | 1.87 | 1.88 | 1.72 | 1.80 | 562,094 | |
| 12/12/2024 | 1.86 | 1.89 | 1.85 | 1.86 | 280,325 | |
| 12/11/2024 | 1.90 | 1.90 | 1.86 | 1.88 | 234,664 | |
| 12/10/2024 | 1.88 | 1.91 | 1.85 | 1.90 | 299,821 | |
| 12/09/2024 | 1.90 | 1.91 | 1.85 | 1.88 | 207,254 | |
| 12/06/2024 | 1.86 | 1.89 | 1.83 | 1.86 | 289,365 | |
| 12/05/2024 | 1.87 | 1.89 | 1.82 | 1.85 | 150,866 | |
| 12/04/2024 | 1.86 | 1.93 | 1.82 | 1.85 | 409,033 | |
| 12/03/2024 | 2.00 | 2.03 | 1.82 | 1.86 | 652,426 | |
| 12/02/2024 | 2.00 | 2.17 | 1.95 | 2.00 | 1,348,844 | |
| 11/29/2024 | 1.91 | 2.00 | 1.90 | 1.99 | 306,835 | |
| 11/27/2024 | 1.84 | 1.91 | 1.84 | 1.87 | 286,043 | |
| 11/26/2024 | 1.88 | 1.89 | 1.83 | 1.85 | 261,014 | |
| 11/25/2024 | 1.85 | 1.89 | 1.84 | 1.85 | 499,567 | |
| 11/22/2024 | 1.86 | 1.87 | 1.81 | 1.84 | 280,283 | |
| 11/21/2024 | 1.85 | 1.88 | 1.80 | 1.85 | 269,624 | |
| 11/20/2024 | 1.75 | 1.91 | 1.73 | 1.86 | 615,561 | |
| 11/19/2024 | 1.69 | 1.77 | 1.68 | 1.74 | 106,429 | |
| 11/18/2024 | 1.71 | 1.77 | 1.68 | 1.70 | 302,042 | |
| 11/15/2024 | 1.81 | 1.81 | 1.68 | 1.70 | 436,076 | |
| 11/14/2024 | 1.87 | 1.88 | 1.75 | 1.81 | 230,959 | |
| 11/13/2024 | 1.84 | 1.86 | 1.66 | 1.84 | 665,780 | |
| 11/12/2024 | 1.92 | 1.97 | 1.82 | 1.87 | 514,204 | |
| 11/11/2024 | 2.01 | 2.09 | 1.90 | 1.94 | 1,192,799 | |
| 11/08/2024 | 1.99 | 2.03 | 1.75 | 1.98 | 815,207 | |
| 11/07/2024 | 1.85 | 2.10 | 1.85 | 1.95 | 1,757,944 | |
| 11/06/2024 | 1.65 | 1.80 | 1.61 | 1.79 | 751,994 | |
| 11/05/2024 | 1.49 | 1.65 | 1.47 | 1.59 | 798,007 | |
| 11/04/2024 | 1.45 | 1.48 | 1.42 | 1.48 | 70,419 | |
| 11/01/2024 | 1.45 | 1.51 | 1.40 | 1.44 | 428,187 | |
| 10/31/2024 | 1.43 | 1.49 | 1.43 | 1.45 | 204,753 | |
| 10/30/2024 | 1.43 | 1.64 | 1.41 | 1.44 | 557,030 | |
| 10/29/2024 | 1.45 | 1.47 | 1.42 | 1.43 | 250,137 | |
| 10/28/2024 | 1.46 | 1.53 | 1.43 | 1.45 | 248,439 | |
| 10/25/2024 | 1.43 | 1.45 | 1.43 | 1.44 | 166,363 | |
| 10/24/2024 | 1.47 | 1.48 | 1.41 | 1.43 | 654,082 | |
| 10/23/2024 | 1.49 | 1.50 | 1.44 | 1.47 | 157,220 | |
| 10/22/2024 | 1.46 | 1.49 | 1.43 | 1.47 | 157,259 | |
| 10/21/2024 | 1.49 | 1.50 | 1.43 | 1.47 | 426,878 | |
| 10/18/2024 | 1.48 | 1.51 | 1.45 | 1.49 | 198,832 | |
| 10/17/2024 | 1.48 | 1.52 | 1.44 | 1.47 | 139,848 | |
| 10/16/2024 | 1.47 | 1.52 | 1.44 | 1.46 | 157,331 | |
| 10/15/2024 | 1.52 | 1.52 | 1.43 | 1.49 | 119,116 | |
| 10/14/2024 | 1.43 | 1.52 | 1.43 | 1.48 | 66,442 | |
| 10/11/2024 | 1.46 | 1.50 | 1.43 | 1.45 | 134,402 | |
| 10/10/2024 | 1.51 | 1.51 | 1.47 | 1.47 | 59,808 | |
| 10/09/2024 | 1.55 | 1.57 | 1.48 | 1.50 | 81,268 | |
| 10/08/2024 | 1.65 | 1.65 | 1.51 | 1.53 | 276,370 |
About Milestone Pharmaceuticals Stock history
Milestone Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Milestone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Milestone Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Milestone Pharmaceuticals stock prices may prove useful in developing a viable investing in Milestone Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 49.4 M | 34.5 M | |
| Net Loss | -52.5 M | -55.2 M |
Milestone Pharmaceuticals Quarterly Net Working Capital |
|
Milestone Pharmaceuticals Stock Technical Analysis
Milestone Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Milestone Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Milestone Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Milestone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Milestone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1528 | |||
| Jensen Alpha | 0.6255 | |||
| Total Risk Alpha | 0.58 | |||
| Sortino Ratio | 0.1826 | |||
| Treynor Ratio | 0.8359 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.